Cargando…
P799: SYNERGISTIC ANTITUMOR ACTIVITY OF THE BCMA 2 + 1 T CELL ENGAGER (TCE) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) AND CELMOD AGENTS IN MULTIPLE MYELOMA (MM) PRECLINICAL MODELS
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430652/ http://dx.doi.org/10.1097/01.HS9.0000970100.80546.2a |
| _version_ | 1785091017745104896 |
|---|---|
| author | Paiva, Bruno Gaffney, Bonny Burnett, Kelven Castiglioni, Paola Angelo, Michael Pierce, Daniel W. Boss, Isaac |
| author_facet | Paiva, Bruno Gaffney, Bonny Burnett, Kelven Castiglioni, Paola Angelo, Michael Pierce, Daniel W. Boss, Isaac |
| author_sort | Paiva, Bruno |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430652 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104306522023-08-17 P799: SYNERGISTIC ANTITUMOR ACTIVITY OF THE BCMA 2 + 1 T CELL ENGAGER (TCE) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) AND CELMOD AGENTS IN MULTIPLE MYELOMA (MM) PRECLINICAL MODELS Paiva, Bruno Gaffney, Bonny Burnett, Kelven Castiglioni, Paola Angelo, Michael Pierce, Daniel W. Boss, Isaac Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430652/ http://dx.doi.org/10.1097/01.HS9.0000970100.80546.2a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Paiva, Bruno Gaffney, Bonny Burnett, Kelven Castiglioni, Paola Angelo, Michael Pierce, Daniel W. Boss, Isaac P799: SYNERGISTIC ANTITUMOR ACTIVITY OF THE BCMA 2 + 1 T CELL ENGAGER (TCE) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) AND CELMOD AGENTS IN MULTIPLE MYELOMA (MM) PRECLINICAL MODELS |
| title | P799: SYNERGISTIC ANTITUMOR ACTIVITY OF THE BCMA 2 + 1 T CELL ENGAGER (TCE) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) AND CELMOD AGENTS IN MULTIPLE MYELOMA (MM) PRECLINICAL MODELS |
| title_full | P799: SYNERGISTIC ANTITUMOR ACTIVITY OF THE BCMA 2 + 1 T CELL ENGAGER (TCE) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) AND CELMOD AGENTS IN MULTIPLE MYELOMA (MM) PRECLINICAL MODELS |
| title_fullStr | P799: SYNERGISTIC ANTITUMOR ACTIVITY OF THE BCMA 2 + 1 T CELL ENGAGER (TCE) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) AND CELMOD AGENTS IN MULTIPLE MYELOMA (MM) PRECLINICAL MODELS |
| title_full_unstemmed | P799: SYNERGISTIC ANTITUMOR ACTIVITY OF THE BCMA 2 + 1 T CELL ENGAGER (TCE) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) AND CELMOD AGENTS IN MULTIPLE MYELOMA (MM) PRECLINICAL MODELS |
| title_short | P799: SYNERGISTIC ANTITUMOR ACTIVITY OF THE BCMA 2 + 1 T CELL ENGAGER (TCE) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) AND CELMOD AGENTS IN MULTIPLE MYELOMA (MM) PRECLINICAL MODELS |
| title_sort | p799: synergistic antitumor activity of the bcma 2 + 1 t cell engager (tce) alnuctamab (alnuc; bms-986349; cc-93269) and celmod agents in multiple myeloma (mm) preclinical models |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430652/ http://dx.doi.org/10.1097/01.HS9.0000970100.80546.2a |
| work_keys_str_mv | AT paivabruno p799synergisticantitumoractivityofthebcma21tcellengagertcealnuctamabalnucbms986349cc93269andcelmodagentsinmultiplemyelomammpreclinicalmodels AT gaffneybonny p799synergisticantitumoractivityofthebcma21tcellengagertcealnuctamabalnucbms986349cc93269andcelmodagentsinmultiplemyelomammpreclinicalmodels AT burnettkelven p799synergisticantitumoractivityofthebcma21tcellengagertcealnuctamabalnucbms986349cc93269andcelmodagentsinmultiplemyelomammpreclinicalmodels AT castiglionipaola p799synergisticantitumoractivityofthebcma21tcellengagertcealnuctamabalnucbms986349cc93269andcelmodagentsinmultiplemyelomammpreclinicalmodels AT angelomichael p799synergisticantitumoractivityofthebcma21tcellengagertcealnuctamabalnucbms986349cc93269andcelmodagentsinmultiplemyelomammpreclinicalmodels AT piercedanielw p799synergisticantitumoractivityofthebcma21tcellengagertcealnuctamabalnucbms986349cc93269andcelmodagentsinmultiplemyelomammpreclinicalmodels AT bossisaac p799synergisticantitumoractivityofthebcma21tcellengagertcealnuctamabalnucbms986349cc93269andcelmodagentsinmultiplemyelomammpreclinicalmodels |